Was Mount Sinai’s Victory in a Dispute Over a Physician’s Credentialing Worth It?
An independent orthopedic surgeon in New York is claiming that he is being unfairly pushed out of a regional hospital owned by Mount Sinai Health System.
An independent orthopedic surgeon in New York is claiming that he is being unfairly pushed out of a regional hospital owned by Mount Sinai Health System.
Underrepresentation of racial and ethnic groups and other historically disenfranchised populations in clinical trials continues to be a major challenge. Medical Affairs can help identify solutions.
Biosimilars represent an important therapeutic option in modern healthcare, offering cost-effective alternatives to complex biological drugs. The educational gap among healthcare professionals poses a challenge to their widespread adoption. Medical Affairs teams in the pharmaceutical industry are at the forefront of bridging this gap
Medical Affairs plays a critical role when it comes to driving adherence to evidence-based medicine (EBM) – the principle that clinical decisions should be informed by the best available scientific evidence, along with clinical experience and patient preference.
With the rapid digitization of the entire industry and a new generation of talent waiting in the wings, Medical affairs teams need access to data and modern technology to engage with a new generation of influencers, improve diversity, and develop stronger go-to-market strategies.